RTKN2 and hepatocellular carcinoma: Hsa_circRNA_104348, for example, is capable of targeting the miR-187-3p/rhotekin 2 (RTKN2) axis and driving the activation of Wnt/β-catenin signaling in a manner conducive to hepatocellular carcinoma progression [7].